Skip to main content

Table 4 Final multivariate linear regression model: variables independently associated with the progression of calcification score during follow-up (n = 163 patients; mean follow up duration = 31.2 ± 3.86 months)

From: Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study

 

β

IC95

p value

Log(calcium score at baseline)

1.02

[1–1.04]

< 0.001

Follow-up duration

0.04

[0.01; 0.06]

0.004

Ischemic cardiomyopathy

0.36

[0.15; 0.57]

0.001

Log(sRANKL)

0.07

[0.02; 0.11]

0.016

Log(OPG/sRANKL)

− 0.06

[− 0.12–0]

0.03

Triglycerides

0.11

[0.03; 0.2]

0.007

Statin use

0.39

[0.06; 0.72]

0.023

  1. OPG osteoprotegerin, sRANKL soluble form of Receptor Activator of Nuclear factor kB Ligand
  2. p-values indicating significance are shown in italics type